世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

にきび治療薬の世界市場規模、現状、予測 2022-2028年


Global Acne Medicine Market Size, Status and Forecast 2022-2028

市場分析と洞察。にきび治療薬の世界市場 Acne Medicineの世界市場規模は、2021年の3491百万米ドルから2028年には4428百万米ドルに達し、2022年から2028年の間にCAGR3.43%で推移すると予測されます。 本レポー... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年5月7日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

市場分析と洞察。にきび治療薬の世界市場
Acne Medicineの世界市場規模は、2021年の3491百万米ドルから2028年には4428百万米ドルに達し、2022年から2028年の間にCAGR3.43%で推移すると予測されます。
本レポートは、業界標準の分析精度と高いデータ整合性により、世界のAcne Medicine市場で利用可能な主要機会を明らかにし、プレイヤーが市場での強力な地位を獲得するのに役立つ素晴らしい試みとなっています。本レポートの購入者は、世界のAcne Medicine市場の全体規模(収益ベース)を含む、検証済みで信頼性の高い市場予測にアクセスすることができます。

全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界のAcne Medicine市場における持続的な成功を確保するために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、世界のAcne Medicine市場を詳細に調査するために、ユニークで業界最高の調査および分析アプローチをとりました。

にきび用医薬品の世界市場範囲と市場規模
アクネメディスン市場は、プレイヤー、地域(国)、タイプ、用途別に分類されます。世界のAcne Medicine市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント分析では、2017年から2028年の期間において、タイプ別の収益と予測、アプリケーション別の収益と予測に焦点を当てます。

企業別
ガルデルマ
バウシュヘルス
テバ
グラクソ・スミスクライン
ビアトリス
アルミラル
サンファーマ
メーンファーマ
ライオン
フアポント
サインファーマ

種類別セグメント
一般用医薬品
医療用医薬品

用途別セグメント
外用剤
経口

地域別
北アメリカ
米国
カナダ
メキシコ

アジア・パシフィック
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア

欧州
ドイツ
フランス
英国
イタリア
ロシア
その他の欧州

南米
ブラジル
南米のその他

中近東・アフリカ
中東
アフリカ

ページTOPに戻る


目次

1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 2
1.2.1 Global Acne Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 2
1.2.2 OTC 3
1.2.3 Prescription Medicine 4
1.3 Market by Application 4
1.3.1 Global Acne Medicine Market Share by Application: 2017 VS 2021 VS 2028 4
1.3.2 Topical 6
1.3.3 Oral 6
1.4 Study Objectives 7
1.5 Years Considered 8
2 GLOBAL GROWTH TRENDS 9
2.1 Global Acne Medicine Market Perspective (2017-2028) 9
2.2 Acne Medicine Growth Trends by Region 10
2.2.1 Acne Medicine Market Size by Region: 2017 VS 2021 VS 2028 10
2.2.2 Acne Medicine Historic Market Size by Region (2017-2022) 12
2.2.3 Acne Medicine Forecasted Market Size by Region (2023-2028) 12
2.3 Acne Medicine Market Dynamics 13
2.3.1 Acne Medicine Industry Trends 13
2.3.2 Acne Medicine Market Drivers 14
2.3.3 Acne Medicine Market Restraints 14
2.3.4 Acne Medicine Market Growth Strategy 15
3 COMPETITION LANDSCAPE BY KEY PLAYERS 16
3.1 Global Top Acne Medicine Players by Revenue 16
3.1.1 Global Top Acne Medicine Players by Revenue (2020-2022) 16
3.1.2 Global Acne Medicine Revenue Market Share by Players (2020-2022) 17
3.2 Global Acne Medicine by Company Type (Tier 1, Tier 2, and Tier 3) 18
3.3 Players Covered: Ranking by Acne Medicine Revenue 19
3.4 Global Acne Medicine Market Concentration Ratio 20
3.4.1 Global Acne Medicine Market Concentration Ratio (CR5 and HHI) 20
3.4.2 Global Top 3 and Top 5 Companies by Acne Medicine Revenue in 2021 21
3.5 Acne Medicine Key Players Head office and Area Served 22
3.6 Key Players Acne Medicine Product Solution and Service 22
3.7 Founded Date of Acne Medicine Players 23
3.8 Mergers & Acquisitions, Expansion Plans 23
4 ACNE MEDICINE BREAKDOWN DATA BY TYPE 25
4.1 Global Acne Medicine Historic Market Size by Type (2017-2022) 25
4.2 Global Acne Medicine Forecasted Market Size by Type (2023-2028) 25
5 ACNE MEDICINE BREAKDOWN DATA BY APPLICATION 27
5.1 Global Acne Medicine Historic Market Size by Application (2017-2022) 27
5.2 Global Acne Medicine Forecasted Market Size by Application (2023-2028) 27
6 NORTH AMERICA 29
6.1 North America Acne Medicine Market Size (2017-2028) 29
6.2 North America Acne Medicine Market Size by Type 29
6.2.1 North America Acne Medicine Market Size by Type (2017-2022) 29
6.2.2 North America Acne Medicine Market Size by Type (2023-2028) 30
6.2.3 North America Acne Medicine Market Share by Type (2017-2028) 30
6.3 North America Acne Medicine Market Size by Application 30
6.3.1 North America Acne Medicine Market Size by Application (2017-2022) 30
6.3.2 North America Acne Medicine Market Size by Application (2023-2028) 31
6.3.3 North America Acne Medicine Market Share by Application (2017-2028) 31
6.4 North America Acne Medicine Market Size by Country 31
6.4.1 North America Acne Medicine Market Size by Country (2017-2022) 31
6.4.2 North America Acne Medicine Market Share by Country (2023-2028) 32
6.4.3 United States 33
6.4.4 Canada 34
6.4.5 Mexico 35
7 EUROPE 36
7.1 Europe Acne Medicine Market Size (2017-2028) 36
7.2 Europe Acne Medicine Market Size by Type 36
7.2.1 Europe Acne Medicine Market Size by Type (2017-2022) 36
7.2.2 Europe Acne Medicine Market Size by Type (2023-2028) 37
7.2.3 Europe Acne Medicine Market Share by Type (2017-2028) 37
7.3 Europe Acne Medicine Market Size by Application 37
7.3.1 Europe Acne Medicine Market Size by Application (2017-2022) 37
7.3.2 Europe Acne Medicine Market Size by Application (2023-2028) 38
7.3.3 Europe Acne Medicine Market Share by Application (2017-2028) 38
7.4 Europe Acne Medicine Market Size by Country 38
7.4.1 Europe Acne Medicine Market Size by Country (2017-2022) 38
7.4.2 Europe Acne Medicine Market Size by Country (2023-2028) 39
7.4.3 Germany 40
7.4.4 France 41
7.4.5 U.K. 42
7.4.6 Italy 43
7.4.7 Russia 44
8 ASIA-PACIFIC 45
8.1 Asia-Pacific Acne Medicine Market Size (2017-2028) 45
8.2 Asia-Pacific Acne Medicine Market Size by Type 45
8.2.1 Asia-Pacific Acne Medicine Market Size by Type (2017-2022) 45
8.2.2 Asia-Pacific Acne Medicine Market Size by Type (2023-2028) 46
8.2.3 Asia-Pacific Acne Medicine Market Share by Type (2017-2028) 46
8.3 Asia-Pacific Acne Medicine Market Size by Application 46
8.3.1 Asia-Pacific Acne Medicine Market Size by Application (2017-2022) 46
8.3.2 Asia-Pacific Acne Medicine Market Size by Application (2023-2028) 47
8.3.3 Asia-Pacific Acne Medicine Market Share by Application (2017-2028) 47
8.4 Asia-Pacific Acne Medicine Market Size by Region 47
8.4.1 Asia-Pacific Acne Medicine Market Size by Region (2017-2022) 47
8.4.2 Asia-Pacific Acne Medicine Market Size by Region (2023-2028) 48
8.4.3 China 49
8.4.4 Japan 50
8.4.5 South Korea 50
8.4.6 Southeast Asia 51
8.4.7 India 51
8.4.8 Australia 52
9 SOUTH AMERICA 53
9.1 South America Acne Medicine Market Size (2017-2028) 53
9.2 South America Acne Medicine Market Size by Type 53
9.2.1 South America Acne Medicine Market Size by Type (2017-2022) 53
9.2.2 South America Acne Medicine Market Size by Type (2023-2028) 54
9.2.3 South America Acne Medicine Market Share by Type (2017-2028) 54
9.3 South America Acne Medicine Market Size by Application 54
9.3.1 South America Acne Medicine Market Size by Application (2017-2022) 54
9.3.2 South America Acne Medicine Market Size by Application (2023-2028) 55
9.3.3 South America Acne Medicine Market Share by Application (2017-2028) 55
9.4 South America Acne Medicine Market Size by Country 55
9.4.1 South America Acne Medicine Market Size by Country (2017-2022) 55
9.4.2 South America Acne Medicine Market Size by Country (2023-2028) 56
9.4.3 Brazil 57
10 MIDDLE EAST & AFRICA 58
10.1 Middle East & Africa Acne Medicine Market Size (2017-2028) 58
10.2 Middle East & Africa Acne Medicine Market Size by Type 58
10.2.1 Middle East & Africa Acne Medicine Market Size by Type (2017-2022) 58
10.2.2 Middle East & Africa Acne Medicine Market Size by Type (2023-2028) 59
10.2.3 Middle East & Africa Acne Medicine Market Share by Type (2017-2028) 59
10.3 Middle East & Africa Acne Medicine Market Size by Application 60
10.3.1 Middle East & Africa Acne Medicine Market Size by Application (2017-2022) 60
10.3.2 Middle East & Africa Acne Medicine Market Size by Application (2023-2028) 60
10.3.3 Middle East & Africa Acne Medicine Market Share by Application (2017-2028) 61
10.4 Middle East & Africa Acne Medicine Market Size by Country 61
10.4.1 Middle East & Africa Acne Medicine Market Size by Country (2017-2022) 61
10.4.2 Middle East & Africa Acne Medicine Market Size by Country (2023-2028) 62
10.4.3 Middle East 63
10.4.4 Africa 63
11 KEY PLAYERS PROFILES 64
11.1 Galderma 64
11.1.1 Galderma Company Details 64
11.1.2 Galderma Company Description and Business Overview 64
11.1.3 Galderma Acne Medicine Introduction 65
11.1.4 Galderma Revenue in Acne Medicine Business (2020-2022) 65
11.1.5 Galderma Recent Development 66
11.2 Bausch Health 67
11.2.1 Bausch Health Company Details 67
11.2.2 Bausch Health Company Description and Business Overview 68
11.2.3 Bausch Health Acne Medicine Introduction 68
11.2.4 Bausch Health Revenue in Acne Medicine Business (2020-2022) 69
11.2.5 Bausch Health Recent Development 69
11.3 Teva 70
11.3.1 Teva Company Details 70
11.3.2 Teva Company Description and Business Overview 71
11.3.3 Teva Acne Medicine Introduction 72
11.3.4 Teva Revenue in Acne Medicine Business (2020-2022) 73
11.3.5 Teva Recent Development 73
11.4 GlaxoSmithKline 73
11.4.1 GlaxoSmithKline Company Details 73
11.4.2 GlaxoSmithKline Company Description and Business Overview 74
11.4.3 GlaxoSmithKline Acne Medicine Introduction 75
11.4.4 GlaxoSmithKline Revenue in Acne Medicine Business (2020-2022) 75
11.4.5 GlaxoSmithKline Recent Development 76
11.5 Viatris (Mylan) 76
11.5.1 Viatris (Mylan) Company Details 76
11.5.2 Viatris (Mylan) Company Description and Business Overview 77
11.5.3 Viatris (Mylan) Acne Medicine Introduction 79
11.5.4 Viatris (Mylan) Revenue in Acne Medicine Business (2020-2022) 79
11.5.5 Viatris (Mylan) Recent Development 79
11.6 Almirall 80
11.6.1 Almirall Company Details 80
11.6.2 Almirall Company Description and Business Overview 81
11.6.3 Almirall Acne Medicine Introduction 81
11.6.4 Almirall Revenue in Acne Medicine Business (2020-2022) 82
11.6.5 Almirall Recent Development 82
11.7 Sun Pharma 83
11.7.1 Sun Pharma Company Details 83
11.7.2 Sun Pharma Company Description and Business Overview 83
11.7.3 Sun Pharma Acne Medicine Introduction 85
11.7.4 Sun Pharma Revenue in Acne Medicine Business (2020-2022) 85
11.7.5 Sun Pharma Recent Development 85
11.8 Mayne Pharma 87
11.8.1 Mayne Pharma Company Details 87
11.8.2 Mayne Pharma Company Description and Business Overview 87
11.8.3 Mayne Pharma Acne Medicine Introduction 88
11.8.4 Mayne Pharma Revenue in Acne Medicine Business (2020-2022) 88
11.8.5 Mayne Pharma Recent Development 89
11.9 Lion 89
11.9.1 Lion Company Details 89
11.9.2 Lion Company Description and Business Overview 89
11.9.3 Lion Acne Medicine Introduction 90
11.9.4 Lion Revenue in Acne Medicine Business (2020-2022) 91
11.10 HUAPONT 92
11.10.1 HUAPONT Company Details 92
11.10.2 HUAPONT Company Description and Business Overview 92
11.10.3 HUAPONT Acne Medicine Introduction 93
11.10.4 HUAPONT Revenue in Acne Medicine Business (2020-2022) 93
11.11 Sine Pharma 93
11.11.1 Sine Pharma Company Details 93
11.11.2 Sine Pharma Company Description and Business Overview 94
11.11.3 Sine Pharma Acne Medicine Introduction 95
11.11.4 Sine Pharma Revenue in Acne Medicine Business (2020-2022) 95
11.11.5 Sine Pharma Recent Development 96
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 97
13 APPENDIX 99
13.1 Research Methodology 99
13.1.1 Methodology/Research Approach 99
13.1.2 Data Source 102
13.2 Disclaimer 105
13.3 Author Details 106

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global Acne Medicine Market
The global Acne Medicine market size is projected to reach US$ 4428 million by 2028, from US$ 3491 million in 2021, at a CAGR of 3.43% during 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acne Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acne Medicine market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acne Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acne Medicine market.

Global Acne Medicine Scope and Market Size
Acne Medicine market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acne Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.

By Company
Galderma
Bausch Health
Teva
GlaxoSmithKline
Viatris
Almirall
Sun Pharma
Mayne Pharma
Lion
HUAPONT
Sine Pharma

Segment by Type
OTC
Prescription Medicine

Segment by Application
Topical
Oral

By Region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia

Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe

South America
Brazil
Rest of South America

Middle East & Africa
Middle East
Africa



ページTOPに戻る


Table of Contents

1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 2
1.2.1 Global Acne Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 2
1.2.2 OTC 3
1.2.3 Prescription Medicine 4
1.3 Market by Application 4
1.3.1 Global Acne Medicine Market Share by Application: 2017 VS 2021 VS 2028 4
1.3.2 Topical 6
1.3.3 Oral 6
1.4 Study Objectives 7
1.5 Years Considered 8
2 GLOBAL GROWTH TRENDS 9
2.1 Global Acne Medicine Market Perspective (2017-2028) 9
2.2 Acne Medicine Growth Trends by Region 10
2.2.1 Acne Medicine Market Size by Region: 2017 VS 2021 VS 2028 10
2.2.2 Acne Medicine Historic Market Size by Region (2017-2022) 12
2.2.3 Acne Medicine Forecasted Market Size by Region (2023-2028) 12
2.3 Acne Medicine Market Dynamics 13
2.3.1 Acne Medicine Industry Trends 13
2.3.2 Acne Medicine Market Drivers 14
2.3.3 Acne Medicine Market Restraints 14
2.3.4 Acne Medicine Market Growth Strategy 15
3 COMPETITION LANDSCAPE BY KEY PLAYERS 16
3.1 Global Top Acne Medicine Players by Revenue 16
3.1.1 Global Top Acne Medicine Players by Revenue (2020-2022) 16
3.1.2 Global Acne Medicine Revenue Market Share by Players (2020-2022) 17
3.2 Global Acne Medicine by Company Type (Tier 1, Tier 2, and Tier 3) 18
3.3 Players Covered: Ranking by Acne Medicine Revenue 19
3.4 Global Acne Medicine Market Concentration Ratio 20
3.4.1 Global Acne Medicine Market Concentration Ratio (CR5 and HHI) 20
3.4.2 Global Top 3 and Top 5 Companies by Acne Medicine Revenue in 2021 21
3.5 Acne Medicine Key Players Head office and Area Served 22
3.6 Key Players Acne Medicine Product Solution and Service 22
3.7 Founded Date of Acne Medicine Players 23
3.8 Mergers & Acquisitions, Expansion Plans 23
4 ACNE MEDICINE BREAKDOWN DATA BY TYPE 25
4.1 Global Acne Medicine Historic Market Size by Type (2017-2022) 25
4.2 Global Acne Medicine Forecasted Market Size by Type (2023-2028) 25
5 ACNE MEDICINE BREAKDOWN DATA BY APPLICATION 27
5.1 Global Acne Medicine Historic Market Size by Application (2017-2022) 27
5.2 Global Acne Medicine Forecasted Market Size by Application (2023-2028) 27
6 NORTH AMERICA 29
6.1 North America Acne Medicine Market Size (2017-2028) 29
6.2 North America Acne Medicine Market Size by Type 29
6.2.1 North America Acne Medicine Market Size by Type (2017-2022) 29
6.2.2 North America Acne Medicine Market Size by Type (2023-2028) 30
6.2.3 North America Acne Medicine Market Share by Type (2017-2028) 30
6.3 North America Acne Medicine Market Size by Application 30
6.3.1 North America Acne Medicine Market Size by Application (2017-2022) 30
6.3.2 North America Acne Medicine Market Size by Application (2023-2028) 31
6.3.3 North America Acne Medicine Market Share by Application (2017-2028) 31
6.4 North America Acne Medicine Market Size by Country 31
6.4.1 North America Acne Medicine Market Size by Country (2017-2022) 31
6.4.2 North America Acne Medicine Market Share by Country (2023-2028) 32
6.4.3 United States 33
6.4.4 Canada 34
6.4.5 Mexico 35
7 EUROPE 36
7.1 Europe Acne Medicine Market Size (2017-2028) 36
7.2 Europe Acne Medicine Market Size by Type 36
7.2.1 Europe Acne Medicine Market Size by Type (2017-2022) 36
7.2.2 Europe Acne Medicine Market Size by Type (2023-2028) 37
7.2.3 Europe Acne Medicine Market Share by Type (2017-2028) 37
7.3 Europe Acne Medicine Market Size by Application 37
7.3.1 Europe Acne Medicine Market Size by Application (2017-2022) 37
7.3.2 Europe Acne Medicine Market Size by Application (2023-2028) 38
7.3.3 Europe Acne Medicine Market Share by Application (2017-2028) 38
7.4 Europe Acne Medicine Market Size by Country 38
7.4.1 Europe Acne Medicine Market Size by Country (2017-2022) 38
7.4.2 Europe Acne Medicine Market Size by Country (2023-2028) 39
7.4.3 Germany 40
7.4.4 France 41
7.4.5 U.K. 42
7.4.6 Italy 43
7.4.7 Russia 44
8 ASIA-PACIFIC 45
8.1 Asia-Pacific Acne Medicine Market Size (2017-2028) 45
8.2 Asia-Pacific Acne Medicine Market Size by Type 45
8.2.1 Asia-Pacific Acne Medicine Market Size by Type (2017-2022) 45
8.2.2 Asia-Pacific Acne Medicine Market Size by Type (2023-2028) 46
8.2.3 Asia-Pacific Acne Medicine Market Share by Type (2017-2028) 46
8.3 Asia-Pacific Acne Medicine Market Size by Application 46
8.3.1 Asia-Pacific Acne Medicine Market Size by Application (2017-2022) 46
8.3.2 Asia-Pacific Acne Medicine Market Size by Application (2023-2028) 47
8.3.3 Asia-Pacific Acne Medicine Market Share by Application (2017-2028) 47
8.4 Asia-Pacific Acne Medicine Market Size by Region 47
8.4.1 Asia-Pacific Acne Medicine Market Size by Region (2017-2022) 47
8.4.2 Asia-Pacific Acne Medicine Market Size by Region (2023-2028) 48
8.4.3 China 49
8.4.4 Japan 50
8.4.5 South Korea 50
8.4.6 Southeast Asia 51
8.4.7 India 51
8.4.8 Australia 52
9 SOUTH AMERICA 53
9.1 South America Acne Medicine Market Size (2017-2028) 53
9.2 South America Acne Medicine Market Size by Type 53
9.2.1 South America Acne Medicine Market Size by Type (2017-2022) 53
9.2.2 South America Acne Medicine Market Size by Type (2023-2028) 54
9.2.3 South America Acne Medicine Market Share by Type (2017-2028) 54
9.3 South America Acne Medicine Market Size by Application 54
9.3.1 South America Acne Medicine Market Size by Application (2017-2022) 54
9.3.2 South America Acne Medicine Market Size by Application (2023-2028) 55
9.3.3 South America Acne Medicine Market Share by Application (2017-2028) 55
9.4 South America Acne Medicine Market Size by Country 55
9.4.1 South America Acne Medicine Market Size by Country (2017-2022) 55
9.4.2 South America Acne Medicine Market Size by Country (2023-2028) 56
9.4.3 Brazil 57
10 MIDDLE EAST & AFRICA 58
10.1 Middle East & Africa Acne Medicine Market Size (2017-2028) 58
10.2 Middle East & Africa Acne Medicine Market Size by Type 58
10.2.1 Middle East & Africa Acne Medicine Market Size by Type (2017-2022) 58
10.2.2 Middle East & Africa Acne Medicine Market Size by Type (2023-2028) 59
10.2.3 Middle East & Africa Acne Medicine Market Share by Type (2017-2028) 59
10.3 Middle East & Africa Acne Medicine Market Size by Application 60
10.3.1 Middle East & Africa Acne Medicine Market Size by Application (2017-2022) 60
10.3.2 Middle East & Africa Acne Medicine Market Size by Application (2023-2028) 60
10.3.3 Middle East & Africa Acne Medicine Market Share by Application (2017-2028) 61
10.4 Middle East & Africa Acne Medicine Market Size by Country 61
10.4.1 Middle East & Africa Acne Medicine Market Size by Country (2017-2022) 61
10.4.2 Middle East & Africa Acne Medicine Market Size by Country (2023-2028) 62
10.4.3 Middle East 63
10.4.4 Africa 63
11 KEY PLAYERS PROFILES 64
11.1 Galderma 64
11.1.1 Galderma Company Details 64
11.1.2 Galderma Company Description and Business Overview 64
11.1.3 Galderma Acne Medicine Introduction 65
11.1.4 Galderma Revenue in Acne Medicine Business (2020-2022) 65
11.1.5 Galderma Recent Development 66
11.2 Bausch Health 67
11.2.1 Bausch Health Company Details 67
11.2.2 Bausch Health Company Description and Business Overview 68
11.2.3 Bausch Health Acne Medicine Introduction 68
11.2.4 Bausch Health Revenue in Acne Medicine Business (2020-2022) 69
11.2.5 Bausch Health Recent Development 69
11.3 Teva 70
11.3.1 Teva Company Details 70
11.3.2 Teva Company Description and Business Overview 71
11.3.3 Teva Acne Medicine Introduction 72
11.3.4 Teva Revenue in Acne Medicine Business (2020-2022) 73
11.3.5 Teva Recent Development 73
11.4 GlaxoSmithKline 73
11.4.1 GlaxoSmithKline Company Details 73
11.4.2 GlaxoSmithKline Company Description and Business Overview 74
11.4.3 GlaxoSmithKline Acne Medicine Introduction 75
11.4.4 GlaxoSmithKline Revenue in Acne Medicine Business (2020-2022) 75
11.4.5 GlaxoSmithKline Recent Development 76
11.5 Viatris (Mylan) 76
11.5.1 Viatris (Mylan) Company Details 76
11.5.2 Viatris (Mylan) Company Description and Business Overview 77
11.5.3 Viatris (Mylan) Acne Medicine Introduction 79
11.5.4 Viatris (Mylan) Revenue in Acne Medicine Business (2020-2022) 79
11.5.5 Viatris (Mylan) Recent Development 79
11.6 Almirall 80
11.6.1 Almirall Company Details 80
11.6.2 Almirall Company Description and Business Overview 81
11.6.3 Almirall Acne Medicine Introduction 81
11.6.4 Almirall Revenue in Acne Medicine Business (2020-2022) 82
11.6.5 Almirall Recent Development 82
11.7 Sun Pharma 83
11.7.1 Sun Pharma Company Details 83
11.7.2 Sun Pharma Company Description and Business Overview 83
11.7.3 Sun Pharma Acne Medicine Introduction 85
11.7.4 Sun Pharma Revenue in Acne Medicine Business (2020-2022) 85
11.7.5 Sun Pharma Recent Development 85
11.8 Mayne Pharma 87
11.8.1 Mayne Pharma Company Details 87
11.8.2 Mayne Pharma Company Description and Business Overview 87
11.8.3 Mayne Pharma Acne Medicine Introduction 88
11.8.4 Mayne Pharma Revenue in Acne Medicine Business (2020-2022) 88
11.8.5 Mayne Pharma Recent Development 89
11.9 Lion 89
11.9.1 Lion Company Details 89
11.9.2 Lion Company Description and Business Overview 89
11.9.3 Lion Acne Medicine Introduction 90
11.9.4 Lion Revenue in Acne Medicine Business (2020-2022) 91
11.10 HUAPONT 92
11.10.1 HUAPONT Company Details 92
11.10.2 HUAPONT Company Description and Business Overview 92
11.10.3 HUAPONT Acne Medicine Introduction 93
11.10.4 HUAPONT Revenue in Acne Medicine Business (2020-2022) 93
11.11 Sine Pharma 93
11.11.1 Sine Pharma Company Details 93
11.11.2 Sine Pharma Company Description and Business Overview 94
11.11.3 Sine Pharma Acne Medicine Introduction 95
11.11.4 Sine Pharma Revenue in Acne Medicine Business (2020-2022) 95
11.11.5 Sine Pharma Recent Development 96
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 97
13 APPENDIX 99
13.1 Research Methodology 99
13.1.1 Methodology/Research Approach 99
13.1.2 Data Source 102
13.2 Disclaimer 105
13.3 Author Details 106

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(薬学的薬物)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る